Mankind Pharma Shareholder Lock-in Period Ended Today, Shares Plunged over 2%
Mankind Pharma’s share price experienced a decline of over 2% on Monday as the lock-in period for shareholders came to an end. As the one-year...
Get Expert Portfolio Analysis
with Unicorn Signals App
